These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32130940)

  • 1. Is there a difference between applicability and generalisability?
    Tugwell P; Knottnerus A
    J Clin Epidemiol; 2020 Mar; 119():A5-A7. PubMed ID: 32130940
    [No Abstract]   [Full Text] [Related]  

  • 2. Randomized trials, observational studies, and the illusive search for the source of truth.
    Gaudino M; Bagiella E; Chang HL; Kurlansky P
    J Thorac Cardiovasc Surg; 2022 Feb; 163(2):757-762. PubMed ID: 33277031
    [No Abstract]   [Full Text] [Related]  

  • 3. Randomized trials analyzed as observational studies.
    Hernán MA; Hernández-Díaz S; Robins JM
    Ann Intern Med; 2013 Oct; 159(8):560-2. PubMed ID: 24018844
    [No Abstract]   [Full Text] [Related]  

  • 4. Randomized  Controlled Trials Versus Real-World Data in the COVID-19 Era: A False Narrative.
    Lyman GH; Kuderer NM
    Cancer Invest; 2020 Nov; 38(10):537-542. PubMed ID: 33090883
    [No Abstract]   [Full Text] [Related]  

  • 5. Observational studies: why are they so important?
    Mariani AW; Pêgo-Fernandes PM
    Sao Paulo Med J; 2014; 132(1):1-2. PubMed ID: 24474072
    [No Abstract]   [Full Text] [Related]  

  • 6. [Not Available].
    Buzzetti R
    Recenti Prog Med; 2019 Nov; 110(11):531. PubMed ID: 31808436
    [No Abstract]   [Full Text] [Related]  

  • 7. Why do we continue to adopt medical practices based on pathophysiology alone when we should be insisting on clinical trials?
    Prasad V; Ho N
    J Clin Epidemiol; 2014 Apr; 67(4):361-3. PubMed ID: 24581292
    [No Abstract]   [Full Text] [Related]  

  • 8. [Not Available].
    Giulio Formoso, per l'Associazione Alessandro Liberati - Network italiano Cochrane
    Recenti Prog Med; 2019 Nov; 110(11):524-525. PubMed ID: 31808432
    [No Abstract]   [Full Text] [Related]  

  • 9. Some common, fatal flaws in systematic reviews of observational studies.
    Wilkinson J; Stocking K
    Fertil Steril; 2024 Jun; 121(6):918-920. PubMed ID: 38309515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninferiority drug trials fail to report adequate methodological detail: an assessment of noninferiority trials from 2010 to 2015.
    Hong J; Tung A; Kinkade A; Tejani AM
    J Clin Epidemiol; 2019 Apr; 108():144-146. PubMed ID: 30529004
    [No Abstract]   [Full Text] [Related]  

  • 11. Study Design in Neurosurgical Research: Considerations for Observational and Experimental Cohort Studies.
    Louie CE; D'Agostino E; Woods A; Ryken T
    Neurosurgery; 2020 Jan; 86(1):14-18. PubMed ID: 31552423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Choosing wisely between randomized controlled trials and observational designs in studies about interventions.
    Ferreira JC; Patino CM
    J Bras Pneumol; 2016; 42(3):165. PubMed ID: 27383927
    [No Abstract]   [Full Text] [Related]  

  • 13. 21st Century Evidence: Randomized Controlled Trials Versus Systematic Reviews and Meta-Analyses.
    Agarwal A; Rochwerg B; Sevransky JE
    Crit Care Med; 2021 Dec; 49(12):2001-2002. PubMed ID: 34582418
    [No Abstract]   [Full Text] [Related]  

  • 14. Reasons for disparity in statin adherence rates between clinical trials and real-world observations: a review.
    Vonbank A; Drexel H; Agewall S; Lewis BS; Dopheide JF; Kjeldsen K; Ceconi C; Savarese G; Rosano G; Wassmann S; Niessner A; Schmidt TA; Saely CH; Baumgartner I; Tamargo J
    Eur Heart J Cardiovasc Pharmacother; 2018 Oct; 4(4):230-236. PubMed ID: 30099530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benchmarking Controlled Trial--a novel concept covering all observational effectiveness studies.
    Malmivaara A
    Ann Med; 2015 Jun; 47(4):332-40. PubMed ID: 25965700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Observational studies using propensity score analysis underestimated the effect sizes in critical care medicine.
    Zhang Z; Ni H; Xu X
    J Clin Epidemiol; 2014 Aug; 67(8):932-9. PubMed ID: 24774469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective Cohort Studies.
    De Rango P
    Eur J Vasc Endovasc Surg; 2016 Jan; 51(1):151. PubMed ID: 26538072
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical research designs to study treatment effects for multidrug-resistant bacteria.
    Paul M; Scudeller L
    Clin Microbiol Infect; 2019 Aug; 25(8):929-931. PubMed ID: 31121323
    [No Abstract]   [Full Text] [Related]  

  • 19. Importance of including harms as well as benefits in all clinical trials.
    Tugwell P; Knottnerus JA
    J Clin Epidemiol; 2018 Mar; 95():v-vi. PubMed ID: 29477217
    [No Abstract]   [Full Text] [Related]  

  • 20. Alternative approaches for confounding adjustment in observational studies using weighting based on the propensity score: a primer for practitioners.
    Desai RJ; Franklin JM
    BMJ; 2019 Oct; 367():l5657. PubMed ID: 31645336
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.